Lucrezia Principi

7PUBLICATIONS
31CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)GlycoconjugatesPharmaceutical delivery technologiesMolecular targetsCheminformatics and quantitative structure-activity relationships
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Feb 13, 2026
Combination with Immunocytokines Enhances the Anticancer Activity of Small Molecule Drug Conjugates and Radioligand Therapeutics Targeting Fibroblast Activation Protein.

Matilde Bocci, Laura Lucaroni, Domenico Ravazza

|Jun 30, 2025
Development of Multivalent FAP-Targeted Small Molecule-Drug Conjugates with Tailored MMAE Release Kinetics.

Matilde Bocci, Lucrezia Principi, Dario Neri

|Mar 04, 2025
PSMA-Targeted Small Molecule-Drug Conjugates Based on a Postprolyl Peptidase-Cleavable Linker for the Treatment of Prostate Cancer.

Tony Georgiev, Sara Puglioli, Lucrezia Principi

|Dec 24, 2024
Delivery of Monomethyl Auristatin F to the Tumor Microenvironment with Noninternalizing Fibroblast Activation Protein-Cleavable Small Molecule-Drug Conjugates Elicits Potent In Vivo Anticancer Activity.

Matilde Bocci, Lucrezia Principi, Ettore Gilardoni

|Jul 03, 2023
A Comparative Analysis of Fibroblast Activation Protein-Targeted Small Molecule-Drug, Antibody-Drug, and Peptide-Drug Conjugates.

Aureliano Zana, Claudia Puig-Moreno, Matilde Bocci

|Mar 11, 2023
Proteomic Fingerprint of Lung Fibrosis Progression and Response to Therapy in Bleomycin-Induced Mouse Model.

Lucrezia Principi, Erica Ferrini, Roberta Ciccimarra

Pageof 2

Frequent Collaborators

5 joint publications

Ettore Gilardoni

4 joint publications

Andrea Galbiati

4 joint publications

Samuele Cazzamalli

4 joint publications

Matilde Bocci